Educational article
Obesity medicines and heart disease: benefits studied and questions to ask
Educational content. It does not replace an individual medical assessment and should not be used for self-medication.

Which health problem is being addressed
Obesity medicines may be studied for weight management or specific health risks. In a heart-health discussion, identify the outcome assessed and the population studied. Bring your heart diagnosis and available reports so the evidence can be put in context.
What SELECT found
SELECT assessed injectable semaglutide in people with overweight or obesity and established cardiovascular disease without diabetes. The combined outcome of cardiovascular death, nonfatal heart attack or nonfatal stroke occurred less often than with placebo alongside usual care.
What existing heart disease means for the discussion
Known heart disease makes a review of the whole treatment plan especially important. Share your cardiology medicines and recent changes. Ask how follow-up would be coordinated and who will review symptoms, tolerability and results.
Which other concerns may be considered
Weight-related concerns can coexist with glucose, blood pressure, lipid or fatty-liver problems. Each needs its own assessment. Your visit can clarify which goals have evidence for the formulation being considered and which other parts of care should continue.
Questions that support a decision
Ask whether the study population resembles your situation, which risks need review and how response will be assessed. Report difficulty staying hydrated or persistent symptoms. Chest pain, severe breathlessness or signs of stroke require emergency care.
Review your situation with the doctor
Attend an in-person or virtual consultation with Dr. Teresita Cortés at Endomédicos to review your history, questions and follow-up. Bring available reports and a list of the products you use.
When to seek medical care
If symptoms persist, test results are abnormal, or you have questions about medication, arrange an individual assessment. Do not change treatment or doses without medical guidance.
Frequently asked questions
Does every weight-loss medicine protect the heart?
Results depend on the product and study population. The doctor can help review which evidence applies to your situation.
Can heart medicines be stopped after weight loss?
Discuss any change with your care team and review your full history.
References
- Semaglutide and cardiovascular outcomes in obesity without diabetes · New England Journal of Medicine
- Wegovy, official prescribing information for injection and tablets · FDA
- Prescription medications to treat overweight and obesity · NIDDK
Does this topic resonate with you?
Every case is different. Book a consultation to review your history, test results and goals with a personalized plan.



